LFST vs. GH, OPCH, RDNT, BTSG, SHC, PRVA, CON, SGRY, ADUS, and VCYT
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs. Its Competitors
LifeStance Health Group (NASDAQ:LFST) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.
In the previous week, Guardant Health had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for Guardant Health and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.99 beat Guardant Health's score of 0.88 indicating that LifeStance Health Group is being referred to more favorably in the media.
LifeStance Health Group currently has a consensus price target of $8.50, indicating a potential upside of 77.82%. Guardant Health has a consensus price target of $53.76, indicating a potential upside of 7.14%. Given LifeStance Health Group's higher probable upside, equities analysts plainly believe LifeStance Health Group is more favorable than Guardant Health.
LifeStance Health Group has a net margin of -2.78% compared to Guardant Health's net margin of -53.82%. Guardant Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.
LifeStance Health Group has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
LifeStance Health Group has higher revenue and earnings than Guardant Health. LifeStance Health Group is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Guardant Health beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 7/3/2025 by MarketBeat.com Staff
Free LFST Stock Alerts